WEKO3
アイテム
{"_buckets": {"deposit": "4e05c6b2-6d36-49a0-931a-caa26fe82787"}, "_deposit": {"created_by": 4, "id": "4098", "owners": [4], "pid": {"revision_id": 0, "type": "depid", "value": "4098"}, "status": "published"}, "_oai": {"id": "oai:hama-med.repo.nii.ac.jp:00004098", "sets": ["17"]}, "author_link": ["12714"], "item_5_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "左室肥大患者におけるPlasma globotriaosylsphingosineを使ったファブリー病の一次スクリーニング", "subitem_alternative_title_language": "ja"}]}, "item_5_biblio_info_5": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2019-08-23", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "9", "bibliographicPageEnd": "1907", "bibliographicPageStart": "1901", "bibliographicVolumeNumber": "83", "bibliographic_titles": [{"bibliographic_title": "Circulation Journal", "bibliographic_titleLang": "en"}]}]}, "item_5_date_granted_17": {"attribute_name": "学位授与年月日", "attribute_value_mlt": [{"subitem_dategranted": "2022-03-14"}]}, "item_5_degree_grantor_15": {"attribute_name": "学位授与機関", "attribute_value_mlt": [{"subitem_degreegrantor": [{"subitem_degreegrantor_language": "ja", "subitem_degreegrantor_name": "浜松医科大学"}], "subitem_degreegrantor_identifier": [{"subitem_degreegrantor_identifier_name": "13802", "subitem_degreegrantor_identifier_scheme": "kakenhi"}]}]}, "item_5_degree_name_12": {"attribute_name": "学位名", "attribute_value_mlt": [{"subitem_degreename": "博士(医学)", "subitem_degreename_language": "ja"}]}, "item_5_description_13": {"attribute_name": "学位の区分", "attribute_value_mlt": [{"subitem_description": "doctoral", "subitem_description_language": "en", "subitem_description_type": "Other"}]}, "item_5_description_14": {"attribute_name": "学位の分野", "attribute_value_mlt": [{"subitem_description": "医学系研究科", "subitem_description_language": "ja", "subitem_description_type": "Other"}]}, "item_5_description_16": {"attribute_name": "報告番号", "attribute_value_mlt": [{"subitem_description": "甲第907号", "subitem_description_language": "ja", "subitem_description_type": "Other"}]}, "item_5_description_9": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Background: Although previous studies have suggested a certain prevalence of Fabry disease (FD) in left ventricular hypertrophy (LVH) patients, the screening of FD is difficult because of its wide-ranging clinical phenotypes. We aimed to clarify the utility of combined measurement of plasma globotriaosylsphingosine (lyso-Gb3) concentration and α-galactosidase A activity (α-GAL) as a primary screening of FD in unexplained LVH patients.\nMethods and Results: Between 2014 and 2016, both lyso-Gb3 and α-GAL were measured in 277 consecutive patients (male 215, female 62, age 25?79 years) with left ventricular wall thickness \u003e12 mm on echocardiogram: 5 patients (1.8%) screened positive (2 (0.7%) showed high lyso-Gb3 and 4 (1.4%) had low α-GAL levels). Finally, 2 patients (0.7%) were diagnosed with clinically significant FD. In 1 case, a female heterozygote with normal α-GAL levels had genetic variants of unknown significance and was diagnosed as FD by endomyocardial biopsy. The other case was a male chronic renal failure patient requiring hemodialysis, and he had a p.R112H mutation. In both cases there were high lyso-Gb3 levels.\nConclusions: The serum lyso-Gb3 level can be relevant for clinically significant FD, and combined measurement of lyso-Gb3 and α-GAL can provide better screening of FD in unexplained LVH patients.", "subitem_description_language": "en", "subitem_description_type": "Abstract"}]}, "item_5_dissertation_number_18": {"attribute_name": "学位授与番号", "attribute_value_mlt": [{"subitem_dissertationnumber": "甲第907号"}]}, "item_5_publisher_6": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "日本循環器学会", "subitem_publisher_language": "ja"}, {"subitem_publisher": "The Japanese Circulation Society", "subitem_publisher_language": "en"}]}, "item_5_relation_26": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "31308318", "subitem_relation_type_select": "PMID"}}]}, "item_5_relation_27": {"attribute_name": "医中誌論文ID", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "2020109846", "subitem_relation_type_select": "ICHUSHI"}}]}, "item_5_relation_28": {"attribute_name": "出版社DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1253/circj.CJ-19-0110", "subitem_relation_type_select": "DOI"}}]}, "item_5_rights_7": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "Copyright 2019 THE JAPANESE CIRCULATION SOCIETY", "subitem_rights_language": "en"}, {"subitem_rights": "This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) License (https://creativecommons.org/licenses/by-nc-nd/4.0/).", "subitem_rights_language": "en"}]}, "item_5_select_2": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"subitem_select_item": "Thesis or Dissertation", "subitem_select_language": "en"}]}, "item_5_source_id_19": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1346-9843", "subitem_source_identifier_type": "PISSN"}]}, "item_5_source_id_20": {"attribute_name": "EISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1347-4820", "subitem_source_identifier_type": "EISSN"}]}, "item_5_version_type_32": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "open access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_abf2"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "山下, 哲史", "creatorNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "12714", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2022-12-01"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "DT_907ronbun.pdf", "filesize": [{"value": "508.1 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_note", "mimetype": "application/pdf", "size": 508100.0, "url": {"label": "論文本文", "objectType": "fulltext", "url": "https://hama-med.repo.nii.ac.jp/record/4098/files/DT_907ronbun.pdf"}, "version_id": "525686d8-2280-459d-bee6-a5ecf24b7dd8"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "α-galactosidase A", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Fabry disease", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Left ventricular hypertrophy", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Lyso-Gb3", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Primary screening", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "doctoral thesis", "resourceuri": "http://purl.org/coar/resource_type/c_db06"}]}, "item_title": "Plasma globotriaosylsphingosine level as a primary screening target for Fabry disease in patients with left ventricular hypertrophy", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Plasma globotriaosylsphingosine level as a primary screening target for Fabry disease in patients with left ventricular hypertrophy", "subitem_title_language": "en"}]}, "item_type_id": "5", "owner": "4", "path": ["17"], "permalink_uri": "http://hdl.handle.net/10271/00004220", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2022-12-01"}, "publish_date": "2022-12-01", "publish_status": "0", "recid": "4098", "relation": {}, "relation_version_is_last": true, "title": ["Plasma globotriaosylsphingosine level as a primary screening target for Fabry disease in patients with left ventricular hypertrophy"], "weko_shared_id": -1}
Plasma globotriaosylsphingosine level as a primary screening target for Fabry disease in patients with left ventricular hypertrophy
http://hdl.handle.net/10271/00004220
http://hdl.handle.net/10271/0000422045b92280-2f9d-4646-bb86-dfad7934e387
名前 / ファイル | ライセンス | アクション |
---|---|---|
論文本文 (508.1 kB)
|
|
Item type | 学位論文 / Thesis or Dissertation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2022-12-01 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | Plasma globotriaosylsphingosine level as a primary screening target for Fabry disease in patients with left ventricular hypertrophy | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | α-galactosidase A | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | Fabry disease | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | Left ventricular hypertrophy | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | Lyso-Gb3 | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | Primary screening | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_db06 | |||||
資源タイプ | doctoral thesis | |||||
アクセス権 | ||||||
アクセス権 | open access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||
その他のタイトル | ||||||
その他のタイトル | 左室肥大患者におけるPlasma globotriaosylsphingosineを使ったファブリー病の一次スクリーニング | |||||
言語 | ja | |||||
著者 |
山下, 哲史
× 山下, 哲史 |
|||||
書誌情報 |
en : Circulation Journal 巻 83, 号 9, p. 1901-1907, 発行日 2019-08-23 |
|||||
出版者 | ||||||
言語 | ja | |||||
出版者 | 日本循環器学会 | |||||
出版者 | ||||||
言語 | en | |||||
出版者 | The Japanese Circulation Society | |||||
権利 | ||||||
言語 | en | |||||
権利情報 | Copyright 2019 THE JAPANESE CIRCULATION SOCIETY | |||||
権利 | ||||||
言語 | en | |||||
権利情報 | This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) License (https://creativecommons.org/licenses/by-nc-nd/4.0/). | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Background: Although previous studies have suggested a certain prevalence of Fabry disease (FD) in left ventricular hypertrophy (LVH) patients, the screening of FD is difficult because of its wide-ranging clinical phenotypes. We aimed to clarify the utility of combined measurement of plasma globotriaosylsphingosine (lyso-Gb3) concentration and α-galactosidase A activity (α-GAL) as a primary screening of FD in unexplained LVH patients. Methods and Results: Between 2014 and 2016, both lyso-Gb3 and α-GAL were measured in 277 consecutive patients (male 215, female 62, age 25?79 years) with left ventricular wall thickness >12 mm on echocardiogram: 5 patients (1.8%) screened positive (2 (0.7%) showed high lyso-Gb3 and 4 (1.4%) had low α-GAL levels). Finally, 2 patients (0.7%) were diagnosed with clinically significant FD. In 1 case, a female heterozygote with normal α-GAL levels had genetic variants of unknown significance and was diagnosed as FD by endomyocardial biopsy. The other case was a male chronic renal failure patient requiring hemodialysis, and he had a p.R112H mutation. In both cases there were high lyso-Gb3 levels. Conclusions: The serum lyso-Gb3 level can be relevant for clinically significant FD, and combined measurement of lyso-Gb3 and α-GAL can provide better screening of FD in unexplained LVH patients. |
|||||
言語 | en | |||||
学位名 | ||||||
言語 | ja | |||||
学位名 | 博士(医学) | |||||
学位の区分 | ||||||
内容記述タイプ | Other | |||||
内容記述 | doctoral | |||||
言語 | en | |||||
学位の分野 | ||||||
内容記述タイプ | Other | |||||
内容記述 | 医学系研究科 | |||||
言語 | ja | |||||
学位授与機関 | ||||||
学位授与機関識別子Scheme | kakenhi | |||||
学位授与機関識別子 | 13802 | |||||
言語 | ja | |||||
学位授与機関名 | 浜松医科大学 | |||||
学位授与年月日 | ||||||
学位授与年月日 | 2022-03-14 | |||||
学位授与番号 | ||||||
学位授与番号 | 甲第907号 | |||||
ISSN | ||||||
収録物識別子タイプ | PISSN | |||||
収録物識別子 | 1346-9843 | |||||
EISSN | ||||||
収録物識別子タイプ | EISSN | |||||
収録物識別子 | 1347-4820 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 31308318 | |||||
医中誌論文ID | ||||||
識別子タイプ | ICHUSHI | |||||
関連識別子 | 2020109846 | |||||
出版社DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.1253/circj.CJ-19-0110 | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 |